{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Molecular dynamics simulation", "Non-nucleoside inhibitors", "Pharmacophore Modeling", "RNA-dependent RNA-polymerase", "SARS-CoV-2", "Virtual Screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36801630", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "20"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jiph.2023.02.009", "S1876-0341(23)00041-2"], "Journal": {"ISSN": "1876-035X", "JournalIssue": {"Volume": "16", "Issue": "4", "PubDate": {"Year": "2023", "Month": "Apr"}}, "Title": "Journal of infection and public health", "ISOAbbreviation": "J Infect Public Health"}, "ArticleTitle": "Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.", "Pagination": {"StartPage": "501", "EndPage": "519", "MedlinePgn": "501-519"}, "Abstract": {"AbstractText": ["The current coronavirus disease-2019 (COVID-19) pandemic has triggered a worldwide health and economic crisis. The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the disease and completes its life cycle using the RNA-dependent RNA-polymerase (RdRp) enzyme, a prominent target for antivirals. In this study, we have computationally screened \u223c690 million compounds from the ZINC20 database and 11,698 small molecule inhibitors from DrugBank to find existing and novel non-nucleoside inhibitors for SARS-CoV-2 RdRp.", "Herein, a combination of the structure-based pharmacophore modeling and hybrid virtual screening methods, including per-residue energy decomposition-based pharmacophore screening, molecular docking, pharmacokinetics, and toxicity evaluation were employed to retrieve novel as well as existing RdRp non-nucleoside inhibitors from large chemical databases. Besides, molecular dynamics simulation and Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) method were used to investigate the binding stability and calculate the binding free energy of RdRp-inhibitor complexes.", "Based on docking scores and significant binding interactions with crucial residues (Lys553, Arg557, Lys623, Cys815, and Ser816) in the RNA binding site of RdRp, three existing drugs, ZINC285540154, ZINC98208626, ZINC28467879, and five compounds from ZINC20 (ZINC739681614, ZINC1166211307, ZINC611516532, ZINC1602963057, and ZINC1398350200) were selected, and the conformational stability of RdRp due to their binding was confirmed through molecular dynamics simulation. The free energy calculations revealed these compounds possess strong binding affinities for RdRp. In addition, these novel inhibitors exhibited drug-like features, good absorption, distribution, metabolism, and excretion profile and were found to be non-toxic.", "The compounds identified in the study by multifold computational strategy can be validated in vitro as potential non-nucleoside inhibitors of SARS-CoV-2 RdRp and holds promise for the discovery of novel drugs against COVID-19 in future."], "CopyrightInformation": "Copyright \u00a9 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biotechnology and Genetic Engineering, The University of Agriculture, Peshawar 25000, Pakistan."}], "LastName": "Aziz", "ForeName": "Shahkaar", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Genetic Engineering, Hazara University Mansehra, 2100, Pakistan; Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Nizwa, Sultanate of Oman."}], "LastName": "Waqas", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Nizwa, Sultanate of Oman."}], "LastName": "Mohanta", "ForeName": "Tapan Kumar", "Initials": "TK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Nizwa, Sultanate of Oman."}], "LastName": "Halim", "ForeName": "Sobia Ahsan", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Biotechnology and Genetic Engineering, The University of Agriculture, Peshawar 25000, Pakistan; Department of Biotechnology, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan. Electronic address: aqib72@aup.edu.pk."}], "LastName": "Iqbal", "ForeName": "Aqib", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology and Genetic Engineering, Hazara University Mansehra, 2100, Pakistan."}], "LastName": "Ali", "ForeName": "Amjad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Substance Abuse and Toxicology Research Center, Jazan University, P.O. Box: 114, Jazan 45142, Saudi Arabia; Medicinal and Aromatic Plants and Traditional Medicine Research Institute, National Center for Research, P. O. Box 2404, Khartoum, Sudan."}], "LastName": "Khalid", "ForeName": "Asaad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia."}], "LastName": "Abdalla", "ForeName": "Ashraf N", "Initials": "AN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Nizwa, Sultanate of Oman. Electronic address: ajmalkhan@unizwa.edu.om."}], "LastName": "Khan", "ForeName": "Ajmal", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural and Medical Sciences Research Center, University of Nizwa, Birkat-ul-Mouz 616, Nizwa, Sultanate of Oman. Electronic address: aharrasi@unizwa.edu.om."}], "LastName": "Al-Harrasi", "ForeName": "Ahmed", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Infect Public Health", "NlmUniqueID": "101487384", "ISSNLinking": "1876-0341"}, "ChemicalList": [{"RegistryNumber": "EC 2.7.7.48", "NameOfSubstance": "RNA-Dependent RNA Polymerase"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "63231-63-0", "NameOfSubstance": "RNA"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "RNA-Dependent RNA Polymerase"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Pharmacophore"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "RNA"}], "CoiStatement": "Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alwafi H., Naser A.Y., Aldhahir A.M., et al. COVID-19 vaccination side effects among the child age group: a large cross-sectional online based survey in Saudi Arabia. BMC Infect Dis. 2022;22:1\u20139.", "ArticleIdList": ["PMC9724422", "36474174"]}, {"Citation": "Yin W., Mao C., Luan X., et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science. 2020;368:1499\u20131504.", "ArticleIdList": ["PMC7199908", "32358203"]}, {"Citation": "Brunese L., Mercaldo F., Reginelli A., Santone A. Explainable deep learning for pulmonary disease and coronavirus COVID-19 detection from X-rays. Comput Methods Prog Biomed. 2020;196", "ArticleIdList": ["PMC7831868", "32599338"]}, {"Citation": "Organization W.H. Weekly epidemiological update on COVID-19 - 7 December 2022, 2022."}, {"Citation": "Khan S., Ali A., Siddique R., Nabi G. Novel coronavirus is putting the whole world on alert. J Hosp Infect. 2020;104:252.", "ArticleIdList": ["PMC7134434", "32032614"]}, {"Citation": "Khan A.I., Shah J.L., Bhat M.M. CoroNet: a deep neural network for detection and diagnosis of COVID-19 from chest x-ray images. Comput Methods Prog Biomed. 2020;196", "ArticleIdList": ["PMC7274128", "32534344"]}, {"Citation": "Koulgi S., Jani V., Uppuladinne M.V.N., Sonavane U., Joshi R. Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. RSC Adv. 2020;10:26792\u201326803.", "ArticleIdList": ["PMC9055499", "35515752"]}, {"Citation": "Zhou P., Yang X.-L., Wang X.-G., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "Chan J.F., Kok K.H., Zhu Z., et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221\u2013236.", "ArticleIdList": ["PMC7067204", "31987001"]}, {"Citation": "Kim D., Lee J.Y., Yang J.S., Kim J.W., Kim V.N., Chang H. The Architecture of SARS-CoV-2 transcriptome. Cell. 2020;181:914\u2013921. e10.", "ArticleIdList": ["PMC7179501", "32330414"]}, {"Citation": "Kirchdoerfer R.N., Ward A.B. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. 2019;10:2342.", "ArticleIdList": ["PMC6538669", "31138817"]}, {"Citation": "Gao Y., Yan L., Huang Y., et al. Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target. BioRxiv 2020."}, {"Citation": "Pushpakom S., Iorio F., Eyers P.A., et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.", "ArticleIdList": ["30310233"]}, {"Citation": "de Farias S.T., Dos Santos Junior A.P., Rego T.G., Jose M.V. Origin and evolution of RNA-dependent RNA polymerase. Front Genet. 2017;8:125.", "ArticleIdList": ["PMC5611760", "28979293"]}, {"Citation": "Furuta Y., Takahashi K., Kuno-Maekawa M., et al. Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother. 2005;49:981\u2013986.", "ArticleIdList": ["PMC549233", "15728892"]}, {"Citation": "Furuta Y., Komeno T., Nakamura T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:449\u2013463.", "ArticleIdList": ["PMC5713175", "28769016"]}, {"Citation": "Graci J.D., Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006;16:37\u201348.", "ArticleIdList": ["PMC7169142", "16287208"]}, {"Citation": "De Clercq E., Li G. Approved antiviral drugs over the past 50 Years. Clin Microbiol Rev. 2016;29:695\u2013747.", "ArticleIdList": ["PMC4978613", "27281742"]}, {"Citation": "Noshi T., Kitano M., Taniguchi K., et al. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Antivir Res. 2018;160:109\u2013117.", "ArticleIdList": ["30316915"]}, {"Citation": "Clark M.P., Ledeboer M.W., Davies I., et al. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. J Med Chem. 2014;57:6668\u20136678.", "ArticleIdList": ["25019388"]}, {"Citation": "Lemm J.A., Liu M., Gentles R.G., et al. Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymerase. Antimicrob Agents Chemother. 2014;58:3485\u20133495.", "ArticleIdList": ["PMC4068470", "24733465"]}, {"Citation": "Lehmann K.C., Gulyaeva A., Zevenhoven-Dobbe J.C., et al. Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses. Nucleic Acids Res. 2015;43:8416\u20138434.", "ArticleIdList": ["PMC4787807", "26304538"]}, {"Citation": "Pan S.Y., Ding M., Huang J., Cai Y., Huang Y.Z. Airway resistance variation correlates with prognosis of critically ill COVID-19 patients: a computational fluid dynamics study. Comput Methods Prog Biomed. 2021;208", "ArticleIdList": ["PMC8231702", "34245951"]}, {"Citation": "Ali M.J., Hanif M., Haider M.A., et al. Treatment options for COVID-19: a review. Front Med (Lausanne) 2020;7:480.", "ArticleIdList": ["PMC7412857", "32850922"]}, {"Citation": "Ullrich S., Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett. 2020", "ArticleIdList": ["PMC7331567", "32738988"]}, {"Citation": "Quimque M.T.J., Notarte K.I.R., Fernandez R.A.T., et al. Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. J Biomol Struct Dyn. 2021;39:4316\u20134333.", "ArticleIdList": ["PMC7309309", "32476574"]}, {"Citation": "Fernandez R.A., Quimque M.T., Notarte K.I., et al. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein. J Biomol Struct Dyn. 2022;40:12209\u201312220.", "ArticleIdList": ["PMC8436362", "34463219"]}, {"Citation": "de Leon V.N.O., Manzano J.A.H., Pilapil D.Y.Ht, et al. Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis. J Genet Eng Biotechnol. 2021;19:104.", "ArticleIdList": ["PMC8284420", "34272647"]}, {"Citation": "Brogi S., Quimque M.T., Notarte K.I., et al. Virtual combinatorial library screening of quinadoline B derivatives against SARS-CoV-2 RNA-dependent RNA polymerase. Computation. 2022;10:7."}, {"Citation": "Tchesnokov E.P., Feng J.Y., Porter D.P., Gotte M. Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by remdesivir. Viruses. 2019;11:326.", "ArticleIdList": ["PMC6520719", "30987343"]}, {"Citation": "Gordon C.J., Tchesnokov E.P., Feng J.Y., Porter D.P., Gotte M. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem. 2020;295:4773\u20134779.", "ArticleIdList": ["PMC7152756", "32094225"]}, {"Citation": "Administration U.F.D. Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment, 2020."}, {"Citation": "Organization W.H. WHO recommends against the use of remdesivir in COVID-19 patients."}, {"Citation": "Robson F., Khan K.S., Le T.K., et al. Coronavirus RNA proofreading: molecular basis and therapeutic targeting. Mol Cell. 2020", "ArticleIdList": ["PMC7833706", "33338403"]}, {"Citation": "Shannon A., Le N.T.-T., Selisko B., et al. Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites. Antivir Res. 2020;178", "ArticleIdList": ["PMC7151495", "32283108"]}, {"Citation": "Notarte K.I., Guerrero-Arguero I., Velasco J.V., et al. Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: a systematic review. J Med Virol. 2022;94:2939\u20132961.", "ArticleIdList": ["PMC9088566", "35229324"]}, {"Citation": "Notarte K.I., Ver A.T., Velasco J.V., et al. Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review. Crit Rev Clin Lab Sci. 2022;59:373\u2013390.", "ArticleIdList": ["PMC8935447", "35220860"]}, {"Citation": "Gerber P.R., Muller K. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry. J Comput Aided Mol Des. 1995;9:251\u2013268.", "ArticleIdList": ["7561977"]}, {"Citation": "Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015;11:3696\u20133713.", "ArticleIdList": ["PMC4821407", "26574453"]}, {"Citation": "Jakalian A., Bush B.L., Jack D.B., Bayly C.I.Fast. efficient generation of high\u2010quality atomic charges. AM1\u2013BCC model: I. Method. J Comput Chem. 2000;21:132\u2013146.", "ArticleIdList": ["12395429"]}, {"Citation": "Salomon-Ferrer R., Gotz A.W., Poole D., Le Grand S., Walker R.C. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh ewald. J Chem Theory Comput. 2013;9:3878\u20133888.", "ArticleIdList": ["26592383"]}, {"Citation": "Case D.A., Belfon K., Ben-Shalom I., et al. Amber 2020. 2020."}, {"Citation": "Tian C., Kasavajhala K., Belfon K.A.A., et al. ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput. 2020;16:528\u2013552.", "ArticleIdList": ["31714766"]}, {"Citation": "Sengupta A., Li Z., Song L.F., Li P., Merz K.M., Jr Parameterization of monovalent ions for the Opc3, Opc, Tip3p-Fb, and Tip4p-Fb water models. J Chem Inf Model. 2021;61:869\u2013880.", "ArticleIdList": ["PMC8173365", "33538599"]}, {"Citation": "Wang B., Merz K.M. A fast QM/MM (Quantum Mechanical/Molecular Mechanical) approach to calculate nuclear magnetic resonance chemical shifts for macromolecules. J Chem Theory Comput. 2006;2:209\u2013215.", "ArticleIdList": ["26626395"]}, {"Citation": "Sindhikara D.J., Kim S., Voter A.F., Roitberg A.E. Bad seeds sprout perilous dynamics: stochastic thermostat induced trajectory synchronization in biomolecules. J Chem Theory Comput. 2009;5:1624\u20131631.", "ArticleIdList": ["26609854"]}, {"Citation": "Kr\u00e4utler V., Van Gunsteren W.F., H\u00fcnenberger P.H. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem. 2001;22:501\u2013508."}, {"Citation": "Darden T., York D., Pedersen L. Particle mesh Ewald: An N\u22c5 log (N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089\u201310092."}, {"Citation": "Miller B.R., III, McGee T.D., Jr, Swails J.M., Homeyer N., Gohlke H., Roitberg A.E. MMPBSA. py: an efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8:3314\u20133321.", "ArticleIdList": ["26605738"]}, {"Citation": "Liu T., Lin Y., Wen X., Jorissen R.N., Gilson M.K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 2007;35:D198\u2013D201.", "ArticleIdList": ["PMC1751547", "17145705"]}, {"Citation": "Mysinger M.M., Carchia M., Irwin J.J., Shoichet B.K. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55:6582\u20136594.", "ArticleIdList": ["PMC3405771", "22716043"]}, {"Citation": "Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett. 2006;27:861\u2013874."}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.", "ArticleIdList": ["PMC5335600", "28256516"]}, {"Citation": "Banerjee P., Eckert A.O., Schrey A.K., Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257\u2013W263.", "ArticleIdList": ["PMC6031011", "29718510"]}, {"Citation": "Roe D.R., Cheatham T.E., 3rd PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9:3084\u20133095.", "ArticleIdList": ["26583988"]}, {"Citation": "Hou T., Wang J., Li Y., Wang W. Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model. 2011;51:69\u201382.", "ArticleIdList": ["PMC3029230", "21117705"]}, {"Citation": "Yang T., Wu J.C., Yan C., et al. Virtual screening using molecular simulations. Proteins. 2011;79:1940\u20131951.", "ArticleIdList": ["PMC3092865", "21491494"]}, {"Citation": "Kollman P.A., Massova I., Reyes C., et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res. 2000;33:889\u2013897.", "ArticleIdList": ["11123888"]}, {"Citation": "Onufriev A., Bashford D., Case D.A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins. 2004;55:383\u2013394.", "ArticleIdList": ["15048829"]}, {"Citation": "Bahar I., Atilgan A.R., Demirel M.C., Erman B. Vibrational dynamics of folded proteins: significance of slow and fast motions in relation to function and stability. Phys Rev Lett. 1998;80:2733."}, {"Citation": "Wen J., Scoles D.R., Facelli J.C. Molecular dynamics analysis of the aggregation propensity of polyglutamine segments. PLoS One. 2017;12", "ArticleIdList": ["PMC5444867", "28542401"]}, {"Citation": "ULC C.C.G. Molecular Operating Environment (MOE), 2020.09, 2020."}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33\u201338. 27-8.", "ArticleIdList": ["8744570"]}, {"Citation": "Schr\u00f6dinger L. The PyMOL molecular graphics system, Version 1.8. 2015. 2018."}, {"Citation": "Community B.O. Blender - a 3D modelling and rendering package, 2018."}, {"Citation": "OriginLab-Corporation. Origin(Pro), 2021."}, {"Citation": "Yin W., Luan X., Li Z., et al. Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin. Nat Struct Mol Biol. 2021;28:319\u2013325.", "ArticleIdList": ["33674802"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23:3\u201325.", "ArticleIdList": ["11259830"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.-Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615\u20132623.", "ArticleIdList": ["12036371"]}, {"Citation": "Muegge I. Selection criteria for drug-like compounds. Med Res Rev. 2003;23:302\u2013321.", "ArticleIdList": ["12647312"]}, {"Citation": "Pathania S., Singh P.K. Vol. 17. Taylor & Francis; 2021. pp. 351\u2013354. (Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?).", "ArticleIdList": ["33320017"]}, {"Citation": "Aftab S.O., Ghouri M.Z., Masood M.U., et al. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. J Transl Med. 2020;18:1\u201315.", "ArticleIdList": ["PMC7339606", "32635935"]}, {"Citation": "Bai X., Sun H., Wu S., Li Y., Wang L., Hong B. Identifying small-molecule inhibitors of SARS-CoV-2 RNA-dpendent RNA polymerase by establishing a fluorometric assay. Front Immunol. 2022;13", "ArticleIdList": ["PMC9021610", "35464436"]}, {"Citation": "Zhang Y.N., Zhang Q.Y., Li X.D., et al. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg Microbes Infect. 2020;9:1170\u20131173.", "ArticleIdList": ["PMC7448857", "32432977"]}, {"Citation": "Opo F.A., Rahman M.M., Ahammad F., Ahmed I., Bhuiyan M.A., Asiri A.M. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci Rep. 2021;11:1\u201317.", "ArticleIdList": ["PMC7892887", "33603068"]}, {"Citation": "Cele F.N., Ramesh M., Soliman M.E. Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential anti-HIV agents. Drug Des, Dev Ther. 2016;10:1365.", "ArticleIdList": ["PMC4833373", "27114700"]}, {"Citation": "Kumalo H., Soliman M.E. Per-residue energy footprints-based pharmacophore modeling as an enhanced in silico approach in drug discovery: a case study on the identification of novel \u03b2-secretase1 (BACE1) inhibitors as anti-Alzheimer agents. Cell Mol Bioeng. 2016;9:175\u2013189."}, {"Citation": "Silakari O., Singh P. Chapter 6\u2014molecular docking analysis: Basic technique to predict drug-receptor interactions. Concepts Exp Protoc Model Inform Drug Des. 2021:131\u2013155."}, {"Citation": "Pokhrel R., Chapagain P., Siltberg-Liberles J. Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2. J Med Microbiol. 2020;69:864.", "ArticleIdList": ["PMC7451031", "32469301"]}, {"Citation": "Pandeya K., Ganeshpurkar A., Mishra M.K. Natural RNA dependent RNA polymerase inhibitors: molecular docking studies of some biologically active alkaloids of Argemone mexicana. Med Hypotheses. 2020;144", "ArticleIdList": ["PMC7262531", "32535456"]}, {"Citation": "Mirza M.U., Froeyen M. Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase. J Pharm Anal. 2020;10:320\u2013328.", "ArticleIdList": ["PMC7187848", "32346490"]}, {"Citation": "Daoui O., Elkhattabi S., Chtita S., Elkhalabi R., Zgou H., Benjelloun A.T. QSAR, molecular docking and ADMET properties in silico studies of novel 4, 5, 6, 7-tetrahydrobenzo [D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase. Heliyon. 2021;7", "ArticleIdList": ["PMC8282965", "34296007"]}, {"Citation": "Ponnan P., Gupta S., Chopra M., et al. 2D-QSAR, docking studies, and in silico ADMET prediction of polyphenolic acetates as substrates for protein acetyltransferase function of glutamine synthetase of Mycobacterium tuberculosis. Int Sch Res Not. 2013;2013"}, {"Citation": "Hollingsworth S.A., Dror R.O. Molecular dynamics simulation for all. Neuron. 2018;99:1129\u20131143.", "ArticleIdList": ["PMC6209097", "30236283"]}, {"Citation": "Maisuradze G.G., Liwo A., Scheraga H.A. Principal component analysis for protein folding dynamics. J Mol Biol. 2009;385:312\u2013329.", "ArticleIdList": ["PMC2652707", "18952103"]}, {"Citation": "Kumar R., Kumar R., Goel H., Tanwar P. Computational investigation reveals that the mutant strains of SARS-CoV2 have differential structural and binding properties. Comput Methods Prog Biomed. 2022;215", "ArticleIdList": ["PMC8685290", "34968787"]}, {"Citation": "Parvez M.S.A., Karim M.A., Hasan M., et al. Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. Int J Biol Macromol. 2020;163:1787\u20131797.", "ArticleIdList": ["PMC7495146", "32950529"]}, {"Citation": "Kasahara K., Fukuda I., Nakamura H. A novel approach of dynamic cross correlation analysis on molecular dynamics simulations and its application to Ets1 dimer-DNA complex. PLoS One. 2014;9", "ArticleIdList": ["PMC4224484", "25380315"]}, {"Citation": "Lippert T., Rarey M. Fast automated placement of polar hydrogen atoms in protein-ligand complexes. J Chemin- 2009;1:13.", "ArticleIdList": ["PMC3225823", "20298519"]}, {"Citation": "Genheden S., Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Disco. 2015;10:449\u2013461.", "ArticleIdList": ["PMC4487606", "25835573"]}, {"Citation": "Du X., Li Y., Xia Y.-L., et al. Insights into protein\u2013ligand interactions: mechanisms, models, and methods. Int J Mol Sci. 2016;17:144.", "ArticleIdList": ["PMC4783878", "26821017"]}, {"Citation": "Berendsen H.J. Computational Molecular Dynamics: Challenges, Methods, Ideas: Proceedings of the 2nd International Symposium on Algorithms for Macromolecular Modelling, Berlin. Springer; 1997. Molecular dynamics simulations: The limits and beyond; pp. 3\u201336. May 21\u201324. May 21\u201324."}, {"Citation": "Durrant J.D., McCammon J.A. Molecular dynamics simulations and drug discovery. BMC Biol. 2011;9:71.", "ArticleIdList": ["PMC3203851", "22035460"]}, {"Citation": "Pinzi L., Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019;20:4331.", "ArticleIdList": ["PMC6769923", "31487867"]}, {"Citation": "Sethi A., Joshi K., Sasikala K., Alvala M. Molecular docking in modern drug discovery: principles and recent applications. Drug Discov Dev-N Adv. 2019;2:1\u201321."}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "1", "Day": "9"}, {"Year": "2023", "Month": "2", "Day": "2"}, {"Year": "2023", "Month": "2", "Day": "9"}, {"Year": "2023", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "21", "Hour": "16", "Minute": "31"}, {"Year": "2023", "Month": "2", "Day": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36801630", "PMC9927802", "10.1016/j.jiph.2023.02.009", "S1876-0341(23)00041-2"]}}], "PubmedBookArticle": []}